Drug Design, Development and Therapy
Volume 15, 2021 - Issue
Original Research
Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study
Eunsol Yang1 Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea
https://orcid.org/0000-0003-2581-349X
https://orcid.org/0000-0003-2581-349X, Hyounggyoon Yoo1 Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Koreahttps://orcid.org/0000-0003-2785-4383
https://orcid.org/0000-0003-2785-4383, In-Jin Jang1 Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Koreahttps://orcid.org/0000-0002-8384-3139
https://orcid.org/0000-0002-8384-3139, Kyung-Sang Yu1 Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Koreahttps://orcid.org/0000-0003-0921-7225
https://orcid.org/0000-0003-0921-7225 & SeungHwan Lee1 Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of KoreaCorrespondence[email protected]
https://orcid.org/0000-0002-1713-9194
https://orcid.org/0000-0002-1713-9194